LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Mime-Version:
1.0
Sender:
Lactation Information and Discussion <[log in to unmask]>
Subject:
From:
Date:
Fri, 6 Oct 2006 09:48:52 +0100
In-Reply-To:
<002d01c6e8f7$476f7210$104fa8c0@lisa>
Content-Type:
text/plain; charset="us-ascii" ; format="flowed"
Reply-To:
Lactation Information and Discussion <[log in to unmask]>
Parts/Attachments:
text/plain (31 lines)
>Heather,
>The question I would ask is if (most likely) the mother was treated in order
>to get pregnant, and if so, for how long.

<snip>

Thanks, Lisa. I will  pass this on.

I don't know what the standard treatment is these days here for 
pituitary tumour, but a quick look around the UK website for GPs and 
others indicates that as you suggest cabergoline seems to be the main 
one. I know bromocriptine has not been in general use for a while.

As you say, cabergoline is known to be long-acting. It would make 
sense that it continued to suppress prolactin.

Heather Welford Neil
NCT, UK

             ***********************************************

To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]

The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(R)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html

ATOM RSS1 RSS2